Alcon Research and Development Expenses 2019-2024 | ALC

Alcon annual/quarterly research and development expenses history and growth rate from 2019 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Alcon research and development expenses for the quarter ending September 30, 2024 were $0.225B, a 11.94% increase year-over-year.
  • Alcon research and development expenses for the twelve months ending September 30, 2024 were $852M, a 4.41% increase year-over-year.
  • Alcon annual research and development expenses for 2023 were $0.828B, a 17.95% increase from 2022.
  • Alcon annual research and development expenses for 2022 were $0.702B, a 16.63% decline from 2021.
  • Alcon annual research and development expenses for 2021 were $0.842B, a 25.11% increase from 2020.
Alcon Annual Research and Development Expenses
(Millions of US $)
2023 $828
2022 $702
2021 $842
2020 $673
2019 $656
2018 $587
Alcon Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $225
2024-06-30 $220
2024-03-31 $199
2023-12-31 $208
2023-09-30 $201
2023-06-30 $217
2023-03-31 $202
2022-12-31 $196
2022-09-30 $159
2022-06-30 $181
2022-03-31 $166
2021-12-31 $180
2021-09-30 $318
2021-06-30 $178
2021-03-31 $166
2020-12-31 $155
2020-09-30 $216
2020-06-30 $163
2020-03-31 $139
2019-12-31 $164
2019-09-30 $179
2019-06-30 $167
2019-03-31 $146
2018-12-31
2018-09-30 $132
2018-06-30 $152
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.414B $9.455B
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $196.322B 23.95
Intuitive Surgical (ISRG) United States $195.140B 102.02
Edwards Lifesciences (EW) United States $41.569B 26.40
IQVIA Holdings (IQV) United States $36.630B 20.18
IDEXX Laboratories (IDXX) United States $34.166B 40.24
DexCom (DXCM) United States $28.447B 42.84
Waters (WAT) United States $22.175B 32.79
STERIS (STE) Ireland $21.157B 24.36
SONOVA HOLDING (SONVY) Switzerland $20.795B 0.00
Hologic (HOLX) United States $18.343B 19.35
Fresenius Medical Care AG KGaA (FMS) Germany $13.004B 13.35
Sysmex ADR (SSMXY) Japan $12.946B 0.00
Globus Medical (GMED) United States $11.536B 29.21
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.260B 44.81
Teleflex (TFX) United States $8.904B 14.20
Glaukos (GKOS) United States $7.940B 0.00
PROCEPT BioRobotics (PRCT) United States $4.884B 0.00
Integer Holdings (ITGR) United States $4.632B 26.26
Veracyte (VCYT) United States $3.068B 92.07
Inari Medical (NARI) United States $2.907B 0.00
LivaNova (LIVN) United Kingdom $2.787B 16.09
TransMedics (TMDX) United States $2.552B 80.89
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.167B 17.66
Tandem Diabetes Care (TNDM) United States $2.023B 0.00
Integra LifeSciences Holdings (IART) United States $1.820B 9.51
RxSight (RXST) United States $1.807B 0.00
Alphatec Holdings (ATEC) United States $1.427B 0.00
Artivion (AORT) United States $1.185B 78.53
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.855B 14.53
Paragon 28 (FNA) United States $0.841B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.723B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.638B 0.00
Mesa Laboratories (MLAB) United States $0.593B 13.97
AxoGen (AXGN) United States $0.587B 0.00
SiBone (SIBN) United States $0.527B 0.00
Pacific Biosciences Of California (PACB) United States $0.493B 0.00
Treace Medical Concepts (TMCI) United States $0.488B 0.00
Semler Scientific (SMLR) United States $0.463B 31.05
Tactile Systems Technology (TCMD) United States $0.428B 23.18
CVRx (CVRX) United States $0.360B 0.00
ClearPoint Neuro (CLPT) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.312B 0.00
NeuroPace (NPCE) United States $0.290B 0.00
AngioDynamics (ANGO) United States $0.278B 0.00
Inogen (INGN) United States $0.223B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
Accuray (ARAY) United States $0.194B 0.00
Nevro (NVRO) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.162B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.60
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
908 Devices (MASS) United States $0.089B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Vicarious Surgical (RBOT) United States $0.068B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Neuronetics (STIM) United States $0.027B 0.00
NexGel (NXGL) United States $0.023B 0.00
Spectral AI (MDAI) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Autonomix Medical (AMIX) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00